Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes

REFERENCES

• Abdel-Azziz MY, Zalata KR, El-Bendary MM: Insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection. Arab J Gastroenterol 11:30–34, 2010.
   Google Scholar
• Jung HJ, Kim YS, Kim SG, Lee YN, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS: The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients. Clin Mol Hepatol 20:38–46, 2014.
   PubMedGoogle Scholar
• Mizuta T, Kawaguchi Y, Eguchi Y, Takahashi H, Ario K, Akiyama T, Oza N, Otsuka T, Kuwashiro T, Yoshimura T, Hisatomi A, Ozaki I: Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load. Dig Dis Sci 55:183–189, 2010.
   PubMed Web of Science ®Google Scholar
• Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, Heimbach JK, Janssen HL, Charlton MR: Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant 9:1406–1413, 2009.
   PubMed Web of Science ®Google Scholar
• Eslam M, Aparcero R, Kawaguchi T, del Campo JA, Sata M, Khattab MA, Romero-Gomez M: Meta-analysis: insulin resistance and sustained virological response in hepatitis C. Aliment Pharmacol Ther 34:297–305, 2011.
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Mizuta T: Interaction between hepatitis C virus and metabolic factors. World J Gastroenterol 20:2888–2901, 2014.
   PubMed Web of Science ®Google Scholar
• Lecube A, Hernandez C, Genesca J, Simo R: Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case–control study. Diabetes Care 29:1096–1101, 2006.
   PubMed Web of Science ®Google Scholar
• Romero-Gomez M, Del MV, Andrade RJ, Salmeron J, Diago M, Fernandez-Rodriguez CM, Corpas R, Cruz M, Grande L, Vazquez L, Munoz-De-Rueda P, Lopez-Serrano P, Gila A, Gutierrez ML, Perez C, Ruiz-Extremera A, Suarez E, Castillo J: Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128:636–641, 2005.
   PubMed Web of Science ®Google Scholar
• World Health Organization: “Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation.” Geneva: World Health Organization (WHO), 2008.
   Google Scholar
• Han TS, van Leer EM, Seidell JC, Lean ME: Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311:1401–1405, 1995.
   PubMed Web of Science ®Google Scholar
• Bray GA: “Contemporary Diagnosis and Management of Obesity.” Newtown, PA: Handbooks in Health Care, 1998.
   Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J: The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062, 2005.
   PubMed Web of Science ®Google Scholar
• Petta S, Camma C, Di M, Calvaruso V, Enea M, Bronte F, Butera G, Cabibi D, Craxi A: Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis. Aliment Pharmacol Ther 30:603–613, 2009.
   PubMed Web of Science ®Google Scholar
• Lonardo A, Ballestri S, Adinolfi LE, Violi E, Carulli L, Lombardini S, Scaglioni F, Ricchi M, Ruggiero G, Loria P: Hepatitis C virus–infected patients are “spared” from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus–related steatosis. Can J Gastroenterol 23:273–278, 2009.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kawaguchi Y, Mizuta T, Kuwashiro T, Oeda S, Oza N, Takahashi H, Iwane S, Eguchi Y, Anzai K, Ozaki I, Fujimoto K: Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C. J Gastroenterol 46:529–535, 2011.
   PubMed Web of Science ®Google Scholar
• Everhart JE, Wright EC: Association of gamma-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology 57:1725–1733, 2013.
   PubMed Web of Science ®Google Scholar
• Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, Tuomilehto J: Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 27:2170–2176, 2006.
   PubMed Web of Science ®Google Scholar
• Benini F, Pigozzi MG, Pozzi A, Bercich L, Reggiani A, Quattrocchi D, Distefano L, Donati P, Cesana BM, Lanzini A: Elevation of serum gamma-glutamyltranspeptidase activity is frequent in chronic hepatitis C, and is associated with insulin resistance. Dig Liver Dis 41:586–590, 2009.
   PubMedGoogle Scholar
• Hotamisligil GS: Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53–S55, 2003.
   PubMed Web of Science ®Google Scholar
• Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, Schick F, Haring H, Stumvoll M: Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res 37:246–251, 2005.
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc 42:2282–2303, 2010.
   PubMed Web of Science ®Google Scholar
• Delgado-Borrego A, Kamegaya Y, Jordan SH, Agrawal S, Valim C, Chung RT: HCV synergizes with body weight in the promotion of insulin resistance. J Viral Hepat 18:135–141, 2011.
   PubMed Web of Science ®Google Scholar
• Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG: Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology 137:549–557, 2009.
   PubMed Web of Science ®Google Scholar
• Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Oza N, Nakashita S, Hara M, Iwane S, Takahashi H, Akiyama T, Ario K, Kawaguchi Y, Yasutake T, Iwakiri R, Ozaki I, Hisatomi A, Eguchi T, Ono N, Fujimoto K: Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation. Liver Int 29:213–220, 2009.
   PubMed Web of Science ®Google Scholar
• Aghemo A, Prati GM, Rumi MG, Soffredini R, D'Ambrosio R, Orsi E, De Nicola S, Degasperi E, Grancini V, Colombo M: Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. Hepatology 56:1681–1687, 2012.
   PubMed Web of Science ®Google Scholar
• Lo IO, Venezia G, Petta S, Mineo C, De LS, Di MV, Rodolico V, Amato M, Ferraro D, Giordano C, Almasio PL, Craxi A: The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther 25:1181–1191, 2007.
   PubMed Web of Science ®Google Scholar
• Tsuzura H, Genda T, Sato S, Hirano K, Kanemitsu Y, Narita Y, Kikuchi T, Iijima K, Wada R, Ichida T: Association of visceral obesity with high viral load and histological findings in elderly patients with genotype 1 chronic hepatitis C. Intern Med 52:1665–1673, 2013.
   PubMed Web of Science ®Google Scholar
• Huang JF, Chuang WL, Yu ML, Yu SH, Huang CF, Huang CI, Yeh ML, Hsieh MH, Yang JF, Lin ZY, Chen SC, Dai CY, Chang WY: Hepatitis C virus infection and metabolic syndrome—a community-based study in an endemic area of Taiwan. Kaohsiung J Med Sci 25:299–305, 2009.
   PubMed Web of Science ®Google Scholar
• Petta S, Di MV, Di SR, Cabibi D, Camma C, Marchesini G, Craxi A: TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. J Viral Hepat 18:e372–e380, 2011.
   PubMed Web of Science ®Google Scholar
• Petta S, Amato M, Cabibi D, Camma C, Di MV, Giordano C, Galluzzo A, Craxi A: Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 52:1543–1552, 2010.
   PubMed Web of Science ®Google Scholar